Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-30

Clinical Trial Update: Study to Estimate How Common it is to Have Genetic Variants Associated With NAFLD

View source ↗

Summary

A completed Janssen-sponsored study aims to estimate how common genetic variants associated with non-alcoholic fatty liver disease are in healthy individuals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Healthy | Status: COMPLETED